Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C24H28N4O6.ClH |
| Molecular Weight | 504.963 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.NC(=N)C1=CC=C(C=C1)C(=O)N[C@@H](CC2=CC=C(O)C=C2)C(=O)N3CCC(CC3)OCC(O)=O
InChI
InChIKey=YUWYXULCUNUQCG-BDQAORGHSA-N
InChI=1S/C24H28N4O6.ClH/c25-22(26)16-3-5-17(6-4-16)23(32)27-20(13-15-1-7-18(29)8-2-15)24(33)28-11-9-19(10-12-28)34-14-21(30)31;/h1-8,19-20,29H,9-14H2,(H3,25,26)(H,27,32)(H,30,31);1H/t20-;/m0./s1
LAMIFIBAN is a potent and selective nonpeptide glycoprotein IIb/IIIa antagonist. It inhibits platelet aggregation and thrombus formation by preventing the binding of fibrinogen to platelets. It was in clinical development as an injectable antithrombotic agent for treating and preventing acute coronary syndromes but showed no significant effects on clinical outcomes.
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL2093869 Sources: https://www.ncbi.nlm.nih.gov/pubmed/8759635 |
1.4 nM [IC50] |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C1327
Created by
admin on Mon Mar 31 18:17:55 GMT 2025 , Edited by admin on Mon Mar 31 18:17:55 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID80947247
Created by
admin on Mon Mar 31 18:17:55 GMT 2025 , Edited by admin on Mon Mar 31 18:17:55 GMT 2025
|
PRIMARY | |||
|
MM-37
Created by
admin on Mon Mar 31 18:17:55 GMT 2025 , Edited by admin on Mon Mar 31 18:17:55 GMT 2025
|
PRIMARY | |||
|
CHEMBL108111
Created by
admin on Mon Mar 31 18:17:55 GMT 2025 , Edited by admin on Mon Mar 31 18:17:55 GMT 2025
|
PRIMARY | |||
|
C81568
Created by
admin on Mon Mar 31 18:17:55 GMT 2025 , Edited by admin on Mon Mar 31 18:17:55 GMT 2025
|
PRIMARY | |||
|
3UZ1CTQ989
Created by
admin on Mon Mar 31 18:17:55 GMT 2025 , Edited by admin on Mon Mar 31 18:17:55 GMT 2025
|
PRIMARY | |||
|
3038483
Created by
admin on Mon Mar 31 18:17:55 GMT 2025 , Edited by admin on Mon Mar 31 18:17:55 GMT 2025
|
PRIMARY | |||
|
243835-65-6
Created by
admin on Mon Mar 31 18:17:55 GMT 2025 , Edited by admin on Mon Mar 31 18:17:55 GMT 2025
|
PRIMARY | |||
|
300000055185
Created by
admin on Mon Mar 31 18:17:55 GMT 2025 , Edited by admin on Mon Mar 31 18:17:55 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD